NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Price Target Raised to C$7.00 at Scotiabank

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) had its price objective increased by equities researchers at Scotiabank from C$6.50 to C$7.00 in a research report issued on Thursday,BayStreet.CA reports. Scotiabank’s target price indicates a potential upside of 26.35% from the stock’s previous close.

NorthWest Health Prop Real Est Inv Trust Stock Down 3.1%

NWH.UN traded down C$0.18 during trading hours on Thursday, hitting C$5.54. 887,343 shares of the company’s stock were exchanged, compared to its average volume of 597,925. The firm has a market cap of C$1.38 billion, a P/E ratio of -13.22, a price-to-earnings-growth ratio of 0.74 and a beta of 1.46. NorthWest Health Prop Real Est Inv Trust has a 12-month low of C$4.33 and a 12-month high of C$5.73. The company has a current ratio of 0.25, a quick ratio of 0.06 and a debt-to-equity ratio of 129.42. The firm has a 50 day moving average of C$5.10 and a 200 day moving average of C$4.96.

NorthWest Health Prop Real Est Inv Trust Company Profile

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.